BF4-33268-30374
4 vaccinations
4 coded responses
16 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 430 / OH
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Registered in v-safe
- 2021-03-08
- 2021-03-09
-
2021-03-23
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: I experienced minor soreness at injection site 1 day after vaccination. This persisted for less than a day. There was no other unusual reaction.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
- 2021-04-12
-
2021-04-15
Survey response — day 21, dose 2MedDRA: Pre-existing disease — Feeling: FairFree text: 1) Sore shoulder and arm, related to physical activities at work - seems unrelated to virus exposure or vaccination. 2) sinus congestion, related to food and pollen allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-29
- 2021-05-06
- 2021-06-26
-
2021-10-07
Dose 3 — Pfizer-BioNTech
- 2022-03-24
-
2022-06-30
Dose 4 — Pfizer-BioNTech
-
2022-08-05
Survey response — day 35, dose 4MedDRA: Brain fog, Cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend schoolFree text: positive test for Covid-19 on 8/4/2022; symptoms preceding testing included minor congestion, occasional coughing, slight brain fog, slight short-term mild feverMedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Survey response — day 42, dose 4MedDRA: Cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid-19 positive via BinaxNOW self-test on 8/4/2022. Some congestion and coughing, brief mild fever on one evening; no severe illness.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-02
- 2022-12-31
- 2023-06-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | No |
| 4 | 2022-06-30 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I experienced minor soreness at injection site 1 day after vaccination. This persisted for less than a day. There was no other unusual reaction.
Release 7 — day 21, dose 2
Symptoms: 1) Sore shoulder and arm, related to physical activities at work - seems unrelated to virus exposure or vaccination. 2) sinus congestion, related to food and pollen allergies.
Release 12 — day 35, dose 4
Symptoms: positive test for Covid-19 on 8/4/2022; symptoms preceding testing included minor congestion, occasional coughing, slight brain fog, slight short-term mild fever
Release 12 — day 42, dose 4
Symptoms: Covid-19 positive via BinaxNOW self-test on 8/4/2022. Some congestion and coughing, brief mild fever on one evening; no severe illness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release